Taisho Pharma : Notice of Change in Taisho Pharmaceutical Co., Ltd.'s Representative Director and Director(Taisho Pharmaceutical Holdings)

May 12, 2014

To Whom It May Concern:

Company Name: Taisho Pharmaceutical Holdings Co., Ltd. Head Office: 3-24-1, Takada, Toshima-ku, Tokyo Representative: Akira Uehara, President and CEO

(First Section of TSE: Code 4581) Contact: Makoto Funahashi, General Manager,

Corporate Communications

(Tel: [phone])

Notice of Change in Taisho Pharmaceutical Co., Ltd.'s Representative Director and Director

Taisho Pharmaceutical Holdings Co., Ltd. has announced that its consolidated subsidiary Taisho Pharmaceutical Co., Ltd. has decided at a meeting of the Board of Directors held today to change a representative director and a director. Details are as follows.
1. Change in Representative Director (As of June 27, 2014) Executive Vice President and Representative Director
Ken Uehara (Currently Senior Managing Director)
2. Change in Director (As of June 27, 2014) Senior Managing Director
Ken-ichi Fujita (Currently Managing Director)

1 / 1